Evidence map›Paper›PMID 24929329›Full record

ReviewMetabolic brain disease2014

Role of astrocytes in thiamine deficiency.

Szeifoul Afadlal, Rémi Labetoulle, Alan S Hazell

Abstract readReview
PubMed Publisher
In one paragraph

Review in Metabolic brain disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Encephalopathy responsive to thiamine in severe COVID-19 patients.Brain, behavior, & immunity - health · 2021
    Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Szeifoul AfadlalDepartamento de Neurologia, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.
Rémi Labetoulle
Alan S Hazell
Universidade Estadual de Campinas (UNICAMP) · BRUniversité de Poitiers · FR

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Thiamine deficiency (TD) is the underlying cause of Wernicke's encephalopathy (WE), an acute neurological disorder characterized by structural damage to key periventricular structures in the brain. Increasing evidence suggests these focal histological lesions may be representative of a gliopathy in which astrocyte-related changes are a major feature of the disorder. These changes include a loss of the glutamate transporters GLT-1 and GLAST concomitant with elevated interstitial glutamate levels, lowered brain pH associated with increased lactate production, decreased levels of GFAP, reduction in the levels of glutamine synthetase, swelling, alterations in levels of aquaporin-4, and disruption of the blood-brain barrier. This review focusses on how these manifestations contribute to the pathophysiology of TD and possibly WE.

Indexed as

Amino Acid Transport System X-AGAnimalsAstrocytesBiological TransportBlood-Brain BarrierBrainDisease Models, AnimalExcitatory Amino Acid Transporter 2Glutamic AcidHumansKetoglutarate Dehydrogenase ComplexNerve Tissue ProteinsNeuronsOxidative StressPyrithiamineThiamine DeficiencyAmino Acid Transport System X-AGExcitatory Amino Acid Transporter 2Glutamic AcidKetoglutarate Dehydrogenase ComplexNerve Tissue ProteinsPyrithiamine

Identifiers

PMID24929329
OpenAlexW2040843559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.